PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase-Reference-Cited by-同舟云学术

PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase

Published:2017-07-13 Issue:7 Volume:12 Page:e0181366
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Alonso-Dominguez Juan M.^ORCID,Casado Luis Felipe,Anguita Eduardo,Gomez-Casares Maria Teresa,Buño Ismael,Ferrer-Marín Francisca,Arenas Alicia,Del Orbe Rafael,Ayala Rosa,Llamas Pilar,Salgado Rocio N.,Osorio Santiago,Sanchez-Godoy Pedro,Burgaleta Carmen,Mahíllo-Fernández Ignacio,Garcia-Gutierrez Valentin,Steegmann Juan Luis,Martinez-Lopez Joaquín

Funder

Fundacion Cris Contra el Cancer

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis;H de Lavallade;J Clin Oncol,2008

2. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia;H Kantarjian;N Engl J Med,2010

3. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia;G Saglio;N Engl J Med,2010

4. Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors;D Marin;J Clin Oncol,2012

5. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013;M Baccarani;Blood,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTCH1 gene variants rs357564, rs2236405, rs2297086 and rs41313327, mRNA and tissue expression in basal cell carcinoma patients from Western Mexico;Journal of Clinical Laboratory Analysis;2024-01-29

2. The association between FOXO3a rs4946936 gene polymorphism and the levels of FOXO3a among chronic granulocytic leukemia patients treated with imatinib mesylate;F1000Research;2022-04-11

3. The association between FOXO3a rs4946936 gene polymorphism and the levels of FOXO3a among chronic granulocytic leukemia patients treated with imatinib mesylate;F1000Research;2022-03-02

4. Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients;HemaSphere;2021-11-30

5. The association between FOXO3a rs4946936 gene polymorphism and the levels of FOXO3a among chronic granulocytic leukemia patients treated with imatinib mesylate;F1000Research;2021-10-04